342 related articles for article (PubMed ID: 31518145)
1. Impacting Pancreatic Cancer Therapy in Heterotypic
Obaid G; Bano S; Mallidi S; Broekgaarden M; Kuriakose J; Silber Z; Bulin AL; Wang Y; Mai Z; Jin W; Simeone D; Hasan T
Nano Lett; 2019 Nov; 19(11):7573-7587. PubMed ID: 31518145
[TBL] [Abstract][Full Text] [Related]
2. Photoimmunotherapy Retains Its Anti-Tumor Efficacy with Increasing Stromal Content in Heterotypic Pancreatic Cancer Spheroids.
Saad MA; Zhung W; Stanley ME; Formica S; Grimaldo-Garcia S; Obaid G; Hasan T
Mol Pharm; 2022 Jul; 19(7):2549-2563. PubMed ID: 35583476
[TBL] [Abstract][Full Text] [Related]
3. Remediating Desmoplasia with EGFR-Targeted Photoactivable Multi-Inhibitor Liposomes Doubles Overall Survival in Pancreatic Cancer.
Obaid G; Bano S; Thomsen H; Callaghan S; Shah N; Swain JWR; Jin W; Ding X; Cameron CG; McFarland SA; Wu J; Vangel M; Stoilova-McPhie S; Zhao J; Mino-Kenudson M; Lin C; Hasan T
Adv Sci (Weinh); 2022 Aug; 9(24):e2104594. PubMed ID: 35748165
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma Models.
Mahajan UM; Li Q; Alnatsha A; Maas J; Orth M; Maier SH; Peterhansl J; Regel I; Sendler M; Wagh PR; Mishra N; Xue Y; Allawadhi P; Beyer G; Kühn JP; Marshall T; Appel B; Lämmerhirt F; Belka C; Müller S; Weiss FU; Lauber K; Lerch MM; Mayerle J
Gastroenterology; 2021 Sep; 161(3):996-1010.e1. PubMed ID: 34097885
[TBL] [Abstract][Full Text] [Related]
5. NIR Photodynamic Destruction of PDAC and HNSCC Nodules Using Triple-Receptor-Targeted Photoimmuno-Nanoconjugates: Targeting Heterogeneity in Cancer.
Bano S; Obaid G; Swain JWR; Yamada M; Pogue BW; Wang K; Hasan T
J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32726945
[TBL] [Abstract][Full Text] [Related]
6. Combined Src/EGFR Inhibition Targets STAT3 Signaling and Induces Stromal Remodeling to Improve Survival in Pancreatic Cancer.
Dosch AR; Dai X; Reyzer ML; Mehra S; Srinivasan S; Willobee BA; Kwon D; Kashikar N; Caprioli R; Merchant NB; Nagathihalli NS
Mol Cancer Res; 2020 Apr; 18(4):623-631. PubMed ID: 31949002
[TBL] [Abstract][Full Text] [Related]
7. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.
Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K
Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719
[No Abstract] [Full Text] [Related]
8. Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma.
Dorst DN; Smeets EMM; Klein C; Frielink C; Geijs D; Trajkovic-Arsic M; Cheung PFY; Stommel MWJ; Gotthardt M; Siveke JT; Aarntzen EHJG; van Lith SAM
Mol Pharm; 2023 Aug; 20(8):4319-4330. PubMed ID: 37485886
[TBL] [Abstract][Full Text] [Related]
9. Photodestruction of Stromal Fibroblasts Enhances Tumor Response to PDT in 3D Pancreatic Cancer Coculture Models.
Karimnia V; Rizvi I; Slack FJ; Celli JP
Photochem Photobiol; 2021 Mar; 97(2):416-426. PubMed ID: 33011973
[TBL] [Abstract][Full Text] [Related]
10. Towards Photodynamic Image-Guided Surgery of Head and Neck Tumors: Photodynamic Priming Improves Delivery and Diagnostic Accuracy of Cetuximab-IRDye800CW.
Bhandari C; Fakhry J; Eroy M; Song JJ; Samkoe K; Hasan T; Hoyt K; Obaid G
Front Oncol; 2022; 12():853660. PubMed ID: 35837101
[TBL] [Abstract][Full Text] [Related]
11. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB
Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma.
Zhao X; Fan W; Xu Z; Chen H; He Y; Yang G; Yang G; Hu H; Tang S; Wang P; Zhang Z; Xu P; Yu M
Oncotarget; 2016 Dec; 7(49):81110-81122. PubMed ID: 27835602
[TBL] [Abstract][Full Text] [Related]
13. Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy.
Koikawa K; Kibe S; Suizu F; Sekino N; Kim N; Manz TD; Pinch BJ; Akshinthala D; Verma A; Gaglia G; Nezu Y; Ke S; Qiu C; Ohuchida K; Oda Y; Lee TH; Wegiel B; Clohessy JG; London N; Santagata S; Wulf GM; Hidalgo M; Muthuswamy SK; Nakamura M; Gray NS; Zhou XZ; Lu KP
Cell; 2021 Sep; 184(18):4753-4771.e27. PubMed ID: 34388391
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 Immune Checkpoint Targeted Photoactivable Liposomes (iTPALs) Prime the Stroma of Pancreatic Tumors and Promote Self-Delivery.
Bhandari C; Moffat A; Shah N; Khan A; Quaye M; Fakhry J; Soma S; Nguyen A; Eroy M; Malkoochi A; Brekken R; Hasan T; Ferruzzi J; Obaid G
Adv Healthc Mater; 2024 Feb; ():e2304340. PubMed ID: 38324463
[TBL] [Abstract][Full Text] [Related]
15. Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D culture platform of pancreatic cancer.
Broekgaarden M; Anbil S; Bulin AL; Obaid G; Mai Z; Baglo Y; Rizvi I; Hasan T
Biomaterials; 2019 Nov; 222():119421. PubMed ID: 31494503
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic priming with triple-receptor targeted nanoconjugates that trigger T cell-mediated immune responses in a 3D
De Silva P; Bano S; Pogue BW; Wang KK; Maytin EV; Hasan T
Nanophotonics; 2021 Sep; 10(12):3199-3214. PubMed ID: 37485044
[TBL] [Abstract][Full Text] [Related]
17. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
18. Immunofluorescence profiling of collagen subtypes is a predictor of treatment outcomes in pancreatic cancer.
Obaid G; Eroy M; Zhao J; Bano S; Mino-Kenudson M; Hasan T
J Photochem Photobiol B; 2024 Jan; 250():112811. PubMed ID: 38000171
[TBL] [Abstract][Full Text] [Related]
19. Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer.
Zhang L; Yao J; Li W; Zhang C
Oncol Res; 2018 Jul; 26(6):827-835. PubMed ID: 28477403
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer.
Tangutoori S; Spring BQ; Mai Z; Palanisami A; Mensah LB; Hasan T
Nanomedicine; 2016 Jan; 12(1):223-34. PubMed ID: 26390832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
